Cargando...
An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment
Recently, metastatic renal cell carcinoma (mRCC) treatment has changed dramatically with the onset of new therapies against molecular targets replacing immunotherapy as standard treatment. We report the case of a 49-year-old patient with a moderately differentiated renal clear cell carcinoma without...
Gardado en:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
S. Karger AG
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251249/ https://ncbi.nlm.nih.gov/pubmed/22220154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000335016 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|